Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationHematopoietic Stem CellsHematopoietic Stem Cell MobilizationTransplantation, AutologousStem CellsLeukapheresisGranulocyte Colony-Stimulating FactorTransplantation, HomologousBlood Component RemovalAntigens, CD34Transplantation ConditioningHematologic NeoplasmsGraft vs Host DiseaseMelphalanBone Marrow TransplantationStem Cell TransplantationCyclophosphamideCombined Modality TherapyGraft SurvivalHematopoiesisBusulfanBlood CellsCord Blood Stem Cell TransplantationMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsBlood Cell CountTreatment OutcomeTissue DonorsMyeloablative AgonistsLymphoma, Non-HodgkinEtoposideAntineoplastic Agents, AlkylatingThiotepaTransplantation ChimeraRecurrenceAdult Stem CellsHistocompatibilityBone Marrow CellsWhole-Body IrradiationRemission InductionColony-Forming Units AssayBone MarrowFlow CytometryCell SeparationStem Cell NicheBlood DonorsCell DifferentiationIfosfamideHistocompatibility TestingEmbryonic Stem CellsLeukemiaStem Cell FactorPlatelet CountBone Marrow PurgingPluripotent Stem CellsDisease-Free SurvivalVidarabineInfectionTime FactorsLeukocytes, MononuclearCytarabineCell LineagePOEMS SyndromeImmunophenotypingCells, CulturedSalvage TherapyRetrospective StudiesImmunomagnetic SeparationTransplantation, IsogeneicFetal BloodRecombinant ProteinsSurvival RateImmunosuppressive AgentsBone Marrow DiseasesVincristineAntigens, CDLeukocyte CountLeukemia, Myeloid, AcuteHodgkin DiseaseNeoplasmsAnemia, AplasticMultipotent Stem CellsSurvival AnalysisProchlorperazinePlatelet TransfusionLymphomaInduced Pluripotent Stem CellsNeural Stem CellsHematologic DiseasesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCarmustineT-LymphocytesFeasibility StudiesLymphocyte DepletionMyelodysplastic SyndromesAmyloidosisCytomegalovirus InfectionsDoxorubicinMesenchymal Stem Cell Transplantation